Cargando…
Concordance of Treatment Recommendations for Metastatic Non-Small-Cell Lung Cancer Between Watson for Oncology System and Medical Team
OBJECTIVE: The disease complexity of metastatic non-small-cell lung cancer (mNSCLC) makes it difficult for physicians to make clinical decisions efficiently and accurately. The Watson for Oncology (WFO) system of artificial intelligence might help physicians by providing fast and precise treatment r...
Autores principales: | You, Hai-Sheng, Gao, Chun-Xia, Wang, Hai-Bin, Luo, Sai-Sai, Chen, Si-Ying, Dong, Ya-Lin, Lyu, Jun, Tian, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083631/ https://www.ncbi.nlm.nih.gov/pubmed/32214852 http://dx.doi.org/10.2147/CMAR.S244932 |
Ejemplares similares
-
Concordance Between Watson for Oncology and Multidisciplinary Teams in Colorectal Cancer: Prognostic Implications and Predicting Concordance
por: Mao, Chenchen, et al.
Publicado: (2020) -
Concordance assessment of Watson for Oncology in breast cancer chemotherapy: first China experience
por: Pan, Hong, et al.
Publicado: (2019) -
Concordance Between Watson for Oncology and a Multidisciplinary Clinical Decision-Making Team for Gastric Cancer and the Prognostic Implications: Retrospective Study
por: Tian, Yulong, et al.
Publicado: (2020) -
Concordance Study Between IBM Watson for Oncology and Real Clinical Practice for Cervical Cancer Patients in China: A Retrospective Analysis
por: Zou, Fang-wen, et al.
Publicado: (2020) -
Concordance Rate between Clinicians and Watson for Oncology among Patients with Advanced Gastric Cancer: Early, Real-World Experience in Korea
por: Choi, Youn I, et al.
Publicado: (2019)